Arkema SA (OTCMKTS:ARKAY – Get Free Report) has been given a consensus rating of “Hold” by the nine brokerages that are currently covering the stock, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the company.
A number of equities research analysts have weighed in on ARKAY shares. Sanford C. Bernstein upgraded Arkema from a “strong sell” rating to a “hold” rating in a research report on Monday, April 20th. Deutsche Bank Aktiengesellschaft restated a “hold” rating on shares of Arkema in a research report on Thursday, April 9th. Berenberg Bank downgraded Arkema from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 20th. The Goldman Sachs Group raised Arkema from a “hold” rating to a “buy” rating in a report on Tuesday, February 10th. Finally, Zacks Research raised Arkema from a “strong sell” rating to a “hold” rating in a report on Monday, May 4th.
Get Our Latest Stock Report on ARKAY
Arkema Stock Performance
Arkema (OTCMKTS:ARKAY – Get Free Report) last released its earnings results on Wednesday, May 6th. The basic materials company reported $1.01 earnings per share for the quarter, topping analysts’ consensus estimates of $0.91 by $0.10. The firm had revenue of $2.57 billion during the quarter, compared to the consensus estimate of $2.52 billion. Arkema had a return on equity of 4.06% and a net margin of 0.46%. On average, equities research analysts forecast that Arkema will post 3.89 EPS for the current year.
Arkema Company Profile
Arkema SA is a global specialty chemicals and advanced materials company headquartered in Colombes, France. Established in 2004 as a spin-off from Total’s chemicals division, the company offers a broad portfolio of high-performance materials designed to improve durability, thermal and chemical resistance, and environmental performance across diverse industries.
Arkema’s operations are organized into four core segments. Adhesive Solutions delivers bonding, sealing, and coating technologies for markets such as packaging, medical devices, and consumer goods.
See Also
- Five stocks we like better than Arkema
- Marvell Stock Soars on NVIDIA’s Trillion-Dollar Nod
- FirstCash Turns Pawn Into a Growth Machine
- HubSpot Just Crushed the Bear CaseāIs a Bigger Rally Ahead?
- Aggressive Insider Buying Signals Opportunity in 3 Risky Stocks
Receive News & Ratings for Arkema Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arkema and related companies with MarketBeat.com's FREE daily email newsletter.
